Alemtuzumab |
Autoimmune conditions (immune thrombocytopenia, anti-glomerular basement membrane disease) Severe infusion reactions Anaphylaxis Cancer (thyroid, melanoma, lymphoproliferative disorders) Infections
|
Axicabtagene ciloleucel |
|
Brexucabtagene autoleucel |
|
Brentuximab vedotin |
|
Ibritumomab tiuxetan |
Severe infusion reactions Severe cytopenia Severe cutaneous/mucocutaneous reactions Do not administer if patient exhibits altered biodistribution
|
Lenalidomide |
Embryo-fetal toxicity (pregnancy must be excluded prior to treatment) Significant neutropenia, thrombocytopenia
|
Obinutuzumab |
|
Rituximab (and biosimilars) |
Severe infusion reactions TLS Severe mucocutaneous reactions PML Hepatitis B virus reactivation
|
Tisagenlecleucel |
|